BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6119937)

  • 1. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; DeFelice EA; Frishman W; Hosler M; Krieger SK; Aglitz N; Kuo PT
    Angiology; 1981 Nov; 32(11):780-7. PubMed ID: 6119937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; Frishman W; Hosler MH; Thorsen NL; Gonasun L; Weinstein J
    Am Heart J; 1982 Aug; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
    Frishman W; Kostis J; Strom J; Hossler M; Elkayam U; Goldner S; Silverman R; Davis R; Weinstein J; Sonnenblick E
    Am Heart J; 1979 Oct; 98(4):526-35. PubMed ID: 39447
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
    Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
    J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-blockers in effort angina].
    Witchitz S; Kolsky H; Moisson P; Philippe B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.
    Berkenboom GM; Ibrahim T; Abramowicz M; Degre SG
    Cardiology; 1987; 74(1):43-8. PubMed ID: 2880663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intrinsic sympathomimetic activity on the ability of hypertensive patients to derive a cardiorespiratory training effect during chronic beta-blockade.
    Duncan JJ; Vaandrager H; Farr JE; Kohl HW; Gordon NF
    Am J Hypertens; 1990 Apr; 3(4):302-6. PubMed ID: 1971751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
    Magder S; Sami M; Ripley R; Lisbona R
    Am J Cardiol; 1987 Jun; 59(15):1289-94. PubMed ID: 3591681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic sympathomimetic activity: clinical fact or fiction?
    Taylor SH
    Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?
    Silke B; Verma SP; Ahuja RC; Hussain M; Hafizullah M; Reynolds G; Nelson GI; Taylor SH
    Eur J Clin Pharmacol; 1984; 27(5):509-15. PubMed ID: 6151504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.